Overview

Translating Research Into Action for Diabetes (TRIAD) is a national multi-center study that was created to determine how managed care systems influence the processes and outcomes of diabetes care. The study will describe and evaluate the quality of care and life among people with diabetes through the help from ten health plans and sixty-six provider groups.
For more information on the Federal Policy for the Protection of Human Subjects, please click here.

Mission

To improve the quality of care and quality of life for people with diabetes.

To provide practical information on how to better implement effective treatments for diabetic patients in the United States managed care settings.

Collaborators

TRIAD includes six Translational Research Centers (TRCs). These centers collaborate with 10 health plans and 66 provider groups, which serve approximately 180,000 patients with diabetes. The health plans participating in TRIAD include staff model health maintenance organizations (HMO), network/IPA model HMOs, point of service (POS) plans, and preferred provider organizations (PPO). These plans include for profit, not-for-profit, Medicare, and Medicaid providers. The 66 provider groups contracting with TRIAD’s partner health plans were also recruited into the study.

Additional collaborators include the Veterans Health Administration's (VHA) and the Social and Behavioral Research Institute (SBRI).

Funding

TRIAD is supported by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and the National Institutes of Health’s (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in Bethesda, Maryland.